Results 41 to 50 of about 4,483 (224)

Two patients with glutaric aciduria type 3: a novel mutation and brain magnetic resonance imaging findings

open access: yesThe Turkish Journal of Pediatrics, 2020
Background. Glutaric Aciduria Type 3 (GA-3) is a rare metabolic disease which is inherited autosomal recessively and characterized by isolated glutaric acid excretion. To date, a limited number of cases have been reported in the literature.
Sevil Dorum   +3 more
doaj   +1 more source

Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I. [PDF]

open access: yesPLoS ONE, 2013
Glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency) is an inborn error of metabolism that usually manifests in infancy by an acute encephalopathic crisis and often results in permanent motor handicap.
Paris Jafari   +5 more
doaj   +1 more source

Clinical and Metabolic Profile of Glutaric Aciduria Type 1 from North India: Tertiary Centre Experience [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Glutaric aciduria type 1 is caused by deficiency of glutaryl-CoA dehydogenase leading to accumulation of glutarylcarnitine in blood and excretion of glutaric acid, 3-hyroxyglutaric acid and glutaconic acid in urine.
Ankur Singh   +3 more
doaj   +1 more source

A rare case of type i glutaric aciduria in an early child

open access: yesМедицинский вестник Юга России, 2020
Glutaric aciduria type I (deficiency of glutaryl-COA dehydrogenase, glutaric acidemia type I) is a rare autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl – COA - dehydrogenase (GCDH).
A. A. Lebedenko   +8 more
doaj   +1 more source

Prenatal diagnosis of fetal glutaric aciduria type 1 with rare compound heterozygous mutations in GCDH gene

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2018
Objective: Glutaric aciduria type 1 is a rare disease, with the estimated prevalence about 1 in 100,000 newborns. GCDH gene mutation can lead to glutaric acid and 3- OH glutaric acid accumulation, with clinical manifestation of neuronal damage, brain ...
Hsiu-Huei Peng   +2 more
doaj   +1 more source

Glutaric aciduria and L-2-hydroxyglutaric aciduria: Clinical and molecular findings of 35 patients from Turkey

open access: yesMolecular Genetics and Metabolism Reports, 2023
Background: Cerebral organic acid disorders are progressive neurometabolic diseases characterized by neurologic dysfunction. Glutaric aciduria type I (GA-I) and L-2-hydroxyglutaric aciduria (L2HGA) are the main cerebral organic acid disorders.
Ayse Ergül Bozaci   +8 more
doaj   +1 more source

Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I [PDF]

open access: yes, 2007
Glutaric acidemia type I (GA-I) is an inherited disorder of lysine and tryptophan metabolism presenting with striatal lesions anatomically and symptomatically similar to Huntington disease.
Banos   +30 more
core   +3 more sources

Organic Aciduria Disorders in Pregnancy: An Overview of Metabolic Considerations

open access: yesMetabolites, 2023
Organic acidurias are a heterogeneous group of rare inherited metabolic disorders (IMDs) caused by a deficiency of an enzyme or a transport protein involved in the intermediary metabolic pathways.
Loai A. Shakerdi   +4 more
doaj   +1 more source

The sodium-dependent di- and tricarboxylate transporter, NaCT, is not responsible for the uptake of D-, L-2-hydroxyglutarate and 3-hydroxyglutarate into neurons [PDF]

open access: yes, 2006
Multi-objective evolutionary algorithms (MOEAs) have become increasingly popular as multi-objective problem solving techniques. Most studies of MOEAs are empirical. Only recently, a few theoretical results have appeared.
Katja Brauburger   +2 more
core   +3 more sources

Glutaric aciduria type 1 presenting with epilepsy [PDF]

open access: yesDevelopmental Medicine & Child Neurology, 2009
Glutaric aciduria type 1 (GA‐1, OMIM 608801) is an autosomal‐recessive disorder resulting from a deficiency of glutaryl‐CoA dehydrogenase (GCDH). Clinical expression usually involves an acute encephalopathic episode in infancy, followed by the development of severe dystonia–dyskinesia. Other presentations include mild developmental delay, macrocephaly,
McClelland, Verity M   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy